632 results on '"Daimon, Takashi"'
Search Results
2. Differences in serum and plasma levels of microRNAs and their time-course changes after blood collection
3. Intratumor hemodynamics using contrast-enhanced MRI in intra-arterial chemotherapy for head and neck cancer
4. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma
5. Heterogeneous reduction in regional wall stress after aortic valve replacement for aortic regurgitation: a distinct feature from aortic stenosis
6. Attenuation by habitual alcohol drinking of the associations of obesity with blood pressure and pulse pressure
7. Designs Considering Toxicity and Efficacy
8. Model-Assisted Designs Considering Toxicity Alone
9. Designs for Early-Phase Immunotherapeutic Agent Trials
10. Model-Based Designs Considering Toxicity Alone
11. Rule-Based Designs Considering Toxicity Alone
12. Early-Phase Cancer Clinical Trials
13. Proton Therapy for Localized Prostate Cancer: Long-Term Results From a Single-Center Experience
14. Dose Finding for Molecularly Targeted Agents (MTAs)
15. Advanced Topics on Dose-Finding Designs
16. Dose Finding for a Combination of Two Agents
17. Dose Finding for Joint Assessment of Both Efficacy and Toxicity
18. Dose Finding in Phase I Cancer Trials
19. Tibial Tubercle–Midepicondyle Distance Can Be a Better Index to Predict the Outcome of Medial Patellofemoral Ligament Reconstruction Than Tibial Tubercle-Trochlear Groove Distance
20. Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa
21. Nocturnal Hypertension and Left Ventricular Diastolic Dysfunction in Patients With Diabetes With the Absence of Heart Failure: Prospective Cohort HSCAA Study
22. Resection of positive tissue on methionine‐PET is associated with improved survival in glioblastomas
23. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types
24. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints
25. Outcomes After Aortic Valve Replacement for Asymptomatic Severe Aortic Regurgitation and Normal Ejection Fraction
26. A randomized phase III study of docetaxel alone versus docetaxel plus S‐1 in patients with previously treated non‐small cell lung cancer: JMTO LC09‐01
27. Outcomes of Patients With Sinonasal Squamous Cell Carcinoma Treated With Particle Therapy Using Protons or Carbon Ions
28. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy
29. Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN)
30. Hematometabolic Index as a New Discriminator of Cardiometabolic Risk in Middle-Aged Men with Polycythemia and High Leukocyte Count in Peripheral Blood
31. Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial
32. Short- versus long-term Dual AntiPlatelet Therapy for Stent-Assisted treatment of CErebral aneurysm (DAPTS ACE): a multicenter, open-label, randomized clinical trial
33. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis
34. Associations between hypo-HDL cholesterolemia and cardiometabolic risk factors in middle-aged men and women: Independence of habitual alcohol drinking, smoking and regular exercise
35. Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study
36. Model-Assisted Designs Considering Toxicity Alone
37. Early-Phase Cancer Clinical Trials
38. Rule-Based Designs Considering Toxicity Alone
39. Model-Based Designs Considering Toxicity Alone
40. Designs for Early-Phase Immunotherapeutic Agent Trials
41. Designs Considering Toxicity and Efficacy
42. Dose-Finding Designs for Early-Phase Cancer Clinical Trials
43. Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR
44. Drug concentration estimation using contrast-enhanced MRI in intra-arterial chemotherapy for head and neck cancers
45. Usefulness of the placebo lead-in design for clinical trials with binary outcomes
46. Outcomes of limited proximal aortic replacement for type A aortic dissection in octogenarians
47. Analysis of risk factors for poor prognosis in conservatively managed early-stage spontaneous osteonecrosis of the knee
48. Diabetes Mellitus Impairs Left Ventricular Mass Regression after Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
49. Dose Finding for Molecularly Targeted Agents (MTAs)
50. Dose Finding in Phase I Cancer Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.